Oncimmune Holdings (LSE:ONC) Days Payable : 243.75 (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Days Payable?

Oncimmune Holdings's average Accounts Payable for the six months ended in Feb. 2024 was £0.98 Mil. Oncimmune Holdings's Cost of Goods Sold for the six months ended in Feb. 2024 was £0.73 Mil. Hence, Oncimmune Holdings's Days Payable for the six months ended in Feb. 2024 was 243.75.

The historical rank and industry rank for Oncimmune Holdings's Days Payable or its related term are showing as below:

LSE:ONC' s Days Payable Range Over the Past 10 Years
Min: 172.58 Med: 334.77 Max: 29869.17
Current: 786.6

During the past 12 years, Oncimmune Holdings's highest Days Payable was 29869.17. The lowest was 172.58. And the median was 334.77.

LSE:ONC's Days Payable is ranked better than
82.35% of 714 companies
in the Biotechnology industry
Industry Median: 127.14 vs LSE:ONC: 786.60

Oncimmune Holdings's Days Payable declined from Feb. 2023 (408.86) to Feb. 2024 (243.75). It may suggest that Oncimmune Holdings accelerated paying its suppliers.

Oncimmune Holdings Days Payable Historical Data

The historical data trend for Oncimmune Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Days Payable Chart

Oncimmune Holdings Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

Aug23

Days Payable

Get a 7-Day Free Trial

172.58

337.13

250.65

284.97

1,082.33

Oncimmune Holdings Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24
Days Payable	Get a 7-Day Free Trial															350.34	215.32	408.86	-	243.75

Competitive Comparison of Oncimmune Holdings's Days Payable

For the Biotechnology subindustry, Oncimmune Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's Days Payable falls into.

Oncimmune Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Oncimmune Holdings's Days Payable for the fiscal year that ended in Aug. 2023 is calculated as

	Days Payable (A: Aug. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: May. 2022 )	+	Accounts Payable (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (1.963	+	0.172)	/	2 )	/	0.36	*	365
=	1.0675					/	0.36	*	365
=	1,082.33

Oncimmune Holdings's Days Payable for the quarter that ended in Feb. 2024 is calculated as:

	Days Payable (Q: Feb. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Aug. 2023 )	+	Accounts Payable (Q: Feb. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Feb. 2024 )	*	Days in Period
=	( (0.172	+	1.778)	/	2 )	/	0.73	*	365 / 2
=	0.975					/	0.73	*	365 / 2
=	243.75

Oncimmune Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB

Website

https://www.oncimmune.com

Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.

Oncimmune Holdings Headlines

No Headlines